$VRTX
VERTEX PHARMACEUTICALS INC / MA

2023 Q3 Form 10-Q Financial Statement

#000087532023000021 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $2.484B $2.493B
YoY Change 6.39% 13.52%
Cost Of Revenue $318.7M $308.6M
YoY Change 10.12% 17.88%
Gross Profit $2.165B $2.185B
YoY Change 5.86% 12.93%
Gross Profit Margin 87.17% 87.62%
Selling, General & Admin $263.8M $262.6M
YoY Change 6.89% 21.97%
% of Gross Profit 12.19% 12.02%
Research & Development $810.0M $896.2M
YoY Change 25.58% 49.34%
% of Gross Profit 37.42% 41.02%
Depreciation & Amortization $42.10M $41.40M
YoY Change 14.71% 10.99%
% of Gross Profit 1.94% 1.9%
Operating Expenses $1.074B $1.158B
YoY Change 20.41% 42.04%
Operating Profit $1.038B $1.026B
YoY Change -7.86% -7.22%
Interest Expense $150.8M $142.7M
YoY Change 364.0% -262.16%
% of Operating Profit 14.53% 13.9%
Other Income/Expense, Net -$15.90M -$7.600M
YoY Change -192.44% -90.27%
Pretax Income $1.179B $1.162B
YoY Change 0.24% 13.38%
Income Tax $143.9M $245.8M
% Of Pretax Income 12.2% 21.16%
Net Earnings $1.035B $915.7M
YoY Change 11.26% 12.98%
Net Earnings / Revenue 41.69% 36.73%
Basic Earnings Per Share $4.01 $3.55
Diluted Earnings Per Share $3.97 $3.52
COMMON SHARES
Basic Shares Outstanding 258.1M shares 257.6M shares
Diluted Shares Outstanding 260.6M shares 260.4M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.93B $11.24B
YoY Change 22.08% 21.43%
Cash & Equivalents $11.11B $10.15B
Short-Term Investments $818.0M $1.085B
Other Short-Term Assets $540.0M $476.9M
YoY Change -25.71% -13.21%
Inventory $688.7M $603.5M
Prepaid Expenses
Receivables $1.539B $1.556B
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.70B $13.87B
YoY Change 19.76% 20.6%
LONG-TERM ASSETS
Property, Plant & Equipment $1.435B $1.447B
YoY Change 28.27% 2.0%
Goodwill $1.088B $1.088B
YoY Change 1.19% 8.56%
Intangibles $603.6M $603.6M
YoY Change 0.0% 55.97%
Long-Term Investments $1.799B $1.456B
YoY Change 1724.54% 1419.73%
Other Assets $475.2M $1.882B
YoY Change 258.64% 1378.48%
Total Long-Term Assets $7.030B $6.476B
YoY Change 58.51% 58.78%
TOTAL ASSETS
Total Short-Term Assets $14.70B $13.87B
Total Long-Term Assets $7.030B $6.476B
Total Assets $21.73B $20.35B
YoY Change 30.05% 30.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $375.9M $363.0M
YoY Change 196.22% 83.33%
Accrued Expenses $2.907B $2.598B
YoY Change 28.39% 22.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.599B $3.352B
YoY Change 37.95% 31.14%
LONG-TERM LIABILITIES
Long-Term Debt $390.0M $404.1M
YoY Change -19.09% -16.21%
Other Long-Term Liabilities $869.3M $1.123B
YoY Change 651.34% 872.96%
Total Long-Term Liabilities $869.3M $1.527B
YoY Change 651.34% 1223.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.599B $3.352B
Total Long-Term Liabilities $869.3M $1.527B
Total Liabilities $5.213B $4.879B
YoY Change 41.79% 33.72%
SHAREHOLDERS EQUITY
Retained Earnings $9.174B $8.138B
YoY Change 60.83% 70.49%
Common Stock $7.342B $7.372B
YoY Change 1.58% 3.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.51B $15.47B
YoY Change
Total Liabilities & Shareholders Equity $21.73B $20.35B
YoY Change 30.05% 30.59%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $1.035B $915.7M
YoY Change 11.26% 12.98%
Depreciation, Depletion And Amortization $42.10M $41.40M
YoY Change 14.71% 10.99%
Cash From Operating Activities $1.268B $1.134B
YoY Change 32.75% -0.47%
INVESTING ACTIVITIES
Capital Expenditures $40.60M $59.60M
YoY Change -174.91% -211.82%
Acquisitions
YoY Change
Other Investing Activities -$77.10M -$244.3M
YoY Change -76.64% 2879.27%
Cash From Investing Activities -$117.7M -$303.9M
YoY Change -69.36% 394.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -165.0M 17.30M
YoY Change 174.09% -63.73%
NET CHANGE
Cash From Operating Activities 1.268B 1.134B
Cash From Investing Activities -117.7M -303.9M
Cash From Financing Activities -165.0M 17.30M
Net Change In Cash 985.7M 847.8M
YoY Change 92.86% -24.71%
FREE CASH FLOW
Cash From Operating Activities $1.268B $1.134B
Capital Expenditures $40.60M $59.60M
Free Cash Flow $1.228B $1.075B
YoY Change 21.6% -9.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
289800000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
242300000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2137500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-112500000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
72800000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
98100000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
161100000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
169700000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
121900000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
21600000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
25600000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2200000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1700000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-277400000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47700000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22000000.0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-31800000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-358600000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1904000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10512000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6800100000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
618700000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
478300000 usd
us-gaap Interest Paid Net
InterestPaidNet
22000000.0 usd
us-gaap Interest Paid Net
InterestPaidNet
27100000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2493200000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2196200000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2493200000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2196200000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
179100000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
159600000 usd
CY2023Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
110500000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
457600000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
915700000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
810500000 usd
us-gaap Net Income Loss
NetIncomeLoss
1615500000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
257700000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
255900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
257600000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0.0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0.0 shares
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0.0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260400000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
258700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260300000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.55
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.27
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.52
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.21
CY2023Q2 us-gaap Cash
Cash
4200000000 usd
CY2022Q4 us-gaap Cash
Cash
3100000000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
129000000.0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2500000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
126500000 usd
CY2023Q2 us-gaap Cash
Cash
4200000000 usd
CY2022Q4 us-gaap Cash
Cash
3100000000 usd
CY2023Q2 vrtx Cash Equivalents And Debt Securities Available For Sale
CashEquivalentsAndDebtSecuritiesAvailableForSale
5911300000 usd
CY2023Q2 vrtx Cash Equivalents And Debt Securities Available For Sale Fair Value Disclosure
CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure
5911300000 usd
CY2022Q4 vrtx Cash Equivalents And Debt Securities Available For Sale
CashEquivalentsAndDebtSecuritiesAvailableForSale
7372900000 usd
CY2022Q4 vrtx Cash Equivalents And Debt Securities Available For Sale Fair Value Disclosure
CashEquivalentsAndDebtSecuritiesAvailableForSaleFairValueDisclosure
7372900000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
72100000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
0 usd
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
19500000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
52600000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
104400000 usd
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
30900000 usd
CY2022 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
18500000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
116800000 usd
CY2023Q2 vrtx Debtand Equity Securities Cost
DebtandEquitySecuritiesCost
2478100000 usd
CY2023Q2 vrtx Debtand Equity Securities Unrealized Gain
DebtandEquitySecuritiesUnrealizedGain
0 usd
CY2023Q2 vrtx Debtand Equity Securities Unrealized Loss
DebtandEquitySecuritiesUnrealizedLoss
35600000 usd
CY2023Q2 vrtx Debtand Equity Securities Fair Value
DebtandEquitySecuritiesFairValue
2442500000 usd
CY2022Q4 vrtx Debtand Equity Securities Cost
DebtandEquitySecuritiesCost
374400000 usd
CY2022Q4 vrtx Debtand Equity Securities Unrealized Gain
DebtandEquitySecuritiesUnrealizedGain
31100000 usd
CY2022Q4 vrtx Debtand Equity Securities Unrealized Loss
DebtandEquitySecuritiesUnrealizedLoss
18800000 usd
CY2022Q4 vrtx Debtand Equity Securities Fair Value
DebtandEquitySecuritiesFairValue
386700000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
6301200000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5642800000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
4943900000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
5530600000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1357300000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
112200000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
6301200000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5642800000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
2130000000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
16100000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
9200000 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-84200000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-900000 usd
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-16900000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
23700000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-40600000 usd
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
92600000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
51000000.0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
41600000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2493200000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2196200000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4868000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1600000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-78100000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2900000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
71800000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
38100000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
398900000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
260700000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
132800000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
161800000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
603500000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
460600000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
600000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-300000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1000000.0 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
119300000 usd
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
113900000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
241700000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
119300000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
113900000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
241700000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
31300000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
26500000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
71900000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
88000000.0 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
87400000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
169800000 usd
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
538505 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
161100000 usd
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2800000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1161500000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1024400000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2053000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
245800000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
213900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
437500000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.212
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.213
CY2023Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
250400000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
208500000 usd
CY2023Q2 vrtx Indemnification Claims
IndemnificationClaims
0 usd
CY2022Q4 vrtx Contingent Liabilities
ContingentLiabilities
0 usd
CY2023Q2 vrtx Contingent Liabilities
ContingentLiabilities
0 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10504000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10151100000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6795000000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8000000.0 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2300000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5100000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10512000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10153400000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6800100000 usd
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000875320-23-000021-index-headers.html Edgar Link pending
0000875320-23-000021-index.html Edgar Link pending
0000875320-23-000021.txt Edgar Link pending
0000875320-23-000021-xbrl.zip Edgar Link pending
a2023q210-qexhibit311.htm Edgar Link pending
a2023q210-qexhibit312.htm Edgar Link pending
a2023q210-qexhibit321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20230630.htm Edgar Link pending
vrtx-20230630.xsd Edgar Link pending
vrtx-20230630_g1.jpg Edgar Link pending
vrtx-20230630_def.xml Edgar Link unprocessable
vrtx-20230630_htm.xml Edgar Link completed
vrtx-20230630_cal.xml Edgar Link unprocessable
vrtx-20230630_lab.xml Edgar Link unprocessable
vrtx-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable